Contributors to psychiatry’s bible, the DSM-5, got $14 million from industry; Courts will decide the future of Medicare’s power to negotiate drug prices within months

Taking stock of the drug industry, from the lab to the medicine chest

January 11, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Contributors to psychiatry's bible, the DSM-5, got $14 million from industry New study raises conflict of interest questions on content contained in bedrock reference book; American Psychiatric Association defends integrity of DSM-5. By Ed Silverman STAT+ | Courts will decide the future of Medicare's power to negotiate drug prices within months Pharmaceutical companies' efforts to scuttle President Biden's program letting Medicare negotiate drug prices will soon face a big test. By Rachel Cohrs STAT+ | A biotech reporter's notebook: Sunshine rains down on San Francisco Whatever the reason, sentiment at this year's J.P. Morgan Healthcare Conference in San Francisco was markedly more positive than in recent years. By Allison DeAngelis

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser